Sullivan, Bruyette, Speros & Blaney’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-5,387
Closed -$339K 203
2018
Q3
$339K Sell
5,387
-1,615
-23% -$97.6K 0.03% 125
2018
Q2
$395K Hold
7,002
0.04% 106
2018
Q1
$390K Hold
7,002
0.04% 109
2017
Q4
$394K Hold
7,002
0.04% 109
2017
Q3
$394K Hold
7,002
0.04% 105
2017
Q2
$383K Hold
7,002
0.04% 103
2017
Q1
$360K Hold
7,002
0.04% 100
2016
Q4
$332K Sell
7,002
-1,000
-12% -$48K 0.03% 106
2016
Q3
$403K Hold
8,002
0.04% 89
2016
Q2
$404K Buy
+8,002
New +$399K 0.04% 83

Other funds holding IXJ

Sullivan, Bruyette, Speros & Blaney's IXJ Position: Q4 2018 in Review

Sullivan, Bruyette, Speros & Blaney sold out of iShares Global Healthcare ETF (IXJ) in Q4 2018, closing a stake of 5,387 shares — an estimated $339K sold.

Sullivan, Bruyette, Speros & Blaney first reported a position in IXJ in Q2 2016 and held it in 10 quarters. The position peaked at $404K in Q2 2016. 201 funds tracked by Wall St. Rank hold IXJ as of Q4 2018.

  • Sullivan, Bruyette, Speros & Blaney reported no remaining iShares Global Healthcare ETF position as of Q4 2018 after selling out during the quarter.
  • Sullivan, Bruyette, Speros & Blaney sold 5,387 iShares Global Healthcare ETF shares in Q4 2018, an estimated $339K.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in iShares Global Healthcare ETF in Q2 2016 and held it in 10 quarters.
  • Sullivan, Bruyette, Speros & Blaney's iShares Global Healthcare ETF position peaked at $404K in Q2 2016.
  • 201 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q4 2018.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q4 2018, filed 7 Feb 2019.